Ultrasound tests to predict early response to prostate and head/neck radiation
Part of Cancer, Digestive system, Kidney & urinary clinical trials.
This study uses special ultrasound imaging to look for early signs of how well radiation treatment is working in prostate, rectum, and head/neck cancers. It may help doctors spot response sooner and adjust care earlier if needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed prostate, rectum, or head-and-neck cancer, and you have not started first-line treatment yet.
- You are planning to receive radiation therapy as your treatment.
- Your doctors can measure the tumor using ultrasound or you had an MRI within the last 28 days.
- Your overall health is strong enough for study participation (ECOG 0–1) and you’re expected to live at least 6 months.
- Recent blood tests show your bone marrow, liver, and kidneys are working well enough (done within 7 days before treatment).
- You can understand the study and will sign consent before any study-specific procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging scan (photoacoustic imaging) to help doctors look at head and neck cancer before treatment. It’s for people who have not had first-line therapy yet and will be starting radiotherapy.
This trial tests a newer, more precise type of radiation therapy for intermediate-risk prostate cancer using micro-ultrasound guidance to target the tumor. It aims to shorten treatment and reduce side effects while maintaining effectiveness.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This study uses MRI scans to see how prostate cancer changes after radiation treatment, especially in the local (prostate-area) response. It may help doctors better judge treatment effectiveness and plan care more precisely.
This study uses repeated MRI scans during radiation treatment to see how tumors change. It may help doctors adjust treatment and improve outcomes for many types of cancer.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.